IE000TTOOBX0 - ITRM (XNAS)

Iterum Therapeutics plc - Ordinary Share Acción

1,77 USD

-2,65 % -0,05 USD 21.12.2024 01:57 - USD - NASDAQ (XNAS) - Precios actuales y gráficos en MoneyPeak

Cotizaciones actuales de Iterum Therapeutics plc - Ordinary Share

Bolsa	Ticker	Moneda	Última operación	Precio	Variación diaria	Variación diaria %
NASDAQ	ITRM	USD	21.12.2024 01:57	1,77 USD	1,77 USD	0,0056 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-2,74 %	0,0056 %	66,99 %	42,75 %	9,27 %	-95,56 %

Company Profile for Iterum Therapeutics plc - Ordinary Share Share

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Company Data for Iterum Therapeutics plc - Ordinary Share Share

Name Iterum Therapeutics plc - Ordinary Share

Company Iterum Therapeutics plc

Symbol ITRM

Website https://www.iterumtx.com

Primary Exchange

NASDAQ

ISIN IE000TTOOBX0

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Corey N. Fishman

Market Capitalization 20 Mio

Country Ireland

Currency USD

Employees 0,0 T

Address Fitzwilliam Court, 2 Dublin

IPO Date 2018-05-25

Ticker Symbols

Name	Symbol
NASDAQ	ITRM

More Shares

Investors who Iterum Therapeutics plc - Ordinary Share hold also have the following shares in their portfolio:

PURETECH HEALTH PLC Share

REP. FSE 13/23 O.A.T. Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Jobs Community Feedback Changelog